COVID-19: NIH begins large clinical trial
Washington – The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and …
Continue readingTag Archives: NIH
Investigational COVID-19 vaccine well-tolerated
Washington – A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine …
Continue reading
Experimental coronavirus vaccine is safe
Washington – Researchers are working to develop a safe and effective vaccine against SARS-CoV-2, the novel coronavirus that causes COVID-19. …
Continue readingClinical trials of monoclonal antibodies now enrolling
Washington – Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by …
Continue reading
Experimental vaccine generates immune response
Washington – An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was …
Continue reading